Clinical trials
Serum clinical trials
Below are recruiting serum clinical trials, each written for real people, not researchers. We’re tracking 190 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03359109Enrolling by invitation
Checking metal levels in children with metal implants
This trial studies how much metal can build up in the body and in the blood in children and teens who will receive certain metal implants during surgery. It may help doctors better understand potential metal exposure and how to monitor it.
Rochester, MinnesotaAges 4–18 - NCT00823654Recruiting
Blood tests during treatment to track ovarian egg supply
This study measures blood biomarkers to understand how breast cancer treatment affects a person’s future fertility (ovarian reserve). It may help patients learn more about egg supply changes after chemotherapy and hormone-related treatments.
Basking Ridge, New JerseyAges 18–44 - NCT00704626Enrolling by invitation
Blood antibody tests in autoimmune brain and nerve diseases
This study looks at blood “auto-antibodies,” which are immune proteins that may attack the body, in people with certain brain and nerve conditions. It may help researchers better understand these diseases and how the immune system is involved.
Sacramento, CaliforniaAges 18 years+ - NCT07411612Recruiting
Blood markers and confusion after surgery in older adults
This study looks at how inflammation and brain-related substances in the blood after surgery are linked to confusion (delirium) in older adults. It aims to find early warning signs to prevent this common complication.
ViennaAges 65 years+ - NCT07464938Recruiting
Predicting brain recovery after cardiac arrest
This study is testing new tools and markers to better predict recovery after cardiac arrest when brain injury may occur. It involves adults who had a cardiac arrest outside the hospital and are being treated at Saint-Luc hospital.
BrusselsAges 18 years+ - NCT07485114Recruiting
Galectin-3 levels in patients on immunotherapy for cancer
This study looks at a protein called galectin-3 in people with certain cancers who are getting immunotherapy (PD-1/PD-L1 inhibitors). It aims to see if galectin-3 levels can help predict how well the treatment works.
Tel Aviv, IsraelAges 18 years+ - NCT07516964Recruiting
Studying autoimmune kidney disease in children and adults
This study collects medical information and samples from patients with podocytopathy—a type of autoimmune kidney disease that causes protein leakage into urine. Researchers will analyze your medical records and any blood or kidney tissue samples you've already had to better understand the disease and find better treatments.
Rochester, MinnesotaAges birth–99 years - NCT07550777Recruiting
Heart Health and Eye Injections Study
This study looks at how repeated eye injections of a drug called bevacizumab affect chemicals in your blood that relate to heart health and inflammation. Researchers want to understand if these eye injections might impact your cardiovascular risk.
Erzurum, ErzurumAges 50–80 - NCT07562997Recruiting
Sodium and Milk Fortification for Premature Babies
This trial tests whether adding sodium and fortified milk to nutrition helps very premature babies grow stronger and develop healthier body composition. Researchers will measure growth and body fat over time to see if these additions improve outcomes.
Cincinnati, OhioAges birth–2 weeks - NCT07591337Recruiting
Study of Aging Blood Vessels and a Protein Called SNRK
This research study examines how blood vessels age over time and how a protein called SNRK may be involved in that process. Researchers want to understand vascular aging (how blood vessels become less flexible as we get older) to potentially help prevent heart and stroke problems.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT07628634RecruitingEarly Phase 1
Testing a Low-Methionine Diet in Solid Tumor Patients
This early-stage study explores whether eating a diet low in methionine (a natural amino acid found in protein) might help people with advanced solid tumors. Researchers will track how this dietary change affects blood levels and may improve treatment outcomes alongside standard cancer care.
Orange, CaliforniaAges 18 years+ - NCT07655180RecruitingPhase 3
Testing a new COVID-19 vaccine with or without another vaccine
This trial tests a new COVID-19 vaccine called VYD2311, alone or with another COVID-19 vaccine, in healthy adults. The goal is to see if it is safe and helps your body fight the virus.
Overland Park, KansasAges 18–49 - NCT07666126Recruiting
Uric acid and gum bone health study
This study looks at whether high uric acid levels affect the bone around your teeth. If you are between 18 and 65, have at least 20 natural teeth, and are either healthy or have high uric acid and gum disease, this trial may be for you.
RizeAges 18–65 - NCT07576036Enrolling by invitation
Study of severe low sodium and brain safety during treatment
This is a retrospective study (meaning researchers look back at medical records) of patients who had very low sodium levels in their blood when admitted to the hospital. Researchers want to understand the link between how quickly doctors correct low sodium and a rare brain condition called osmotic demyelination syndrome.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT07565064Enrolling by invitation
Vitamin D Blood Test Stability Study
This study tests how accurately a vitamin D blood test works with fresh versus frozen samples. Your blood samples will help researchers understand the best way to store and measure vitamin D levels.
Salem, New HampshireAges 22 years+ - NCT07499713Enrolling by invitation
Blood proteins and nail blood vessels in alopecia areata
This study looks at whether certain proteins in your blood (VEGF-A and VCAM-1) are linked to changes in the tiny blood vessels at the base of your fingernails in people with alopecia areata. It may help doctors understand more about the condition and how it affects the body.
IstanbulAges 18–60 - NCT07346274Enrolling by invitation
Blood pressure during surgery and recovery after Whipple procedure
This trial looks at how low blood pressure during a Whipple procedure (pancreaticoduodenectomy) affects lactate levels after surgery, which is a marker of how well your body is recovering. It helps doctors understand how to manage blood pressure to improve outcomes.
Milan, MilanAges 18–80 - NCT07050706Enrolling by invitation
Heart failure and protein levels in the blood
This trial checks if a protein called PRMT5 in the blood is linked to heart function in people with heart failure. It compares healthy volunteers and those with heart failure to see if this protein can help understand the condition better.
Shenzhen, GuangdongAges 18 years+ - NCT07033676Enrolling by invitation
Study of a blood marker for heart damage from high blood pressure
This trial looks at a substance in your blood called miR-455-5p to see if it can help doctors understand heart changes caused by high blood pressure. It involves people who have had high blood pressure for over a year and may have some heart symptoms.
Shenzhen, GuangdongAges 18 years+ - NCT06906536Enrolling by invitation
Intermittent low oxygen to improve leg function after spinal injury
This trial tests whether short, controlled sessions of low oxygen (like breathing thin air) can improve leg movement and blood markers in people with spinal cord injuries. It may help with walking or standing.
Boulder, ColoradoAges 18–75 - NCT06540508Enrolling by invitation
TACE with targeted immunotherapy for advanced liver cancer
This study looks at whether combining a liver-directed procedure called TACE with tiragolumab and targeted therapy works better for people with unresectable liver cancer that has not spread too far. Researchers will use blood and tissue tests to see how well the treatment works.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06463964Enrolling by invitation
Predicting kidney injury in emergency heart failure patients
This study looks at what factors might predict acute kidney injury (sudden kidney damage) in people who come to the emergency room with acute decompensated heart failure (a sudden worsening of heart failure). The goal is to help doctors identify who is at highest risk so they can take steps to protect the kidneys.
SohagAges 18 years+
Hear when a new Serum trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for serum?
- Yes. Clin2 currently lists 190 recruiting serum studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a serum trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a serum trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.